SYF Synchrony Financial
AI brief AI-written, not reviewed by a person
Latest period figures show liquidity and profitability metrics improving year over year in several lines: cash and equivalents for 2026-09-30 are 15.901 billion vs 16.193 billion at 2026-06-30 and 20.559 billion at 2026-03-31; diluted EPS for 12 months to 2025-12-31 is 9.28 USD/shares vs 8.55 for 2024-12-31; stockholders’ equity at 2026-09-30 is 16.55 billion vs 16.897 billion at 2026-06-30 and 16.476 billion at 2026-03-31. Net income for the trailing year to 2025-12-31 is 3.552 billion, up from 3.499 billion in 2024- Net income for the quarter ended 2026-09-30 is 892 million, higher than the prior quarter. Operating cash flow for the year ended 2025-12-31 is 9.851 billion, roughly flat versus 9.848 billion in 2024-12-31.
- Cash and equivalents declined from 16.193 billion at 2026-06-30 to 15.901 billion at 2026-09-30; the year-to-date values indicate a decrease within the latest quarter window. [1]
- Diluted EPS (year) for 12 months to 2025-12-31 is 9.28 USD; 12 months to 2024-12-31 is 8.55 USD. [1]
- Diluted EPS (quarter) for 3 months to 2026-09-30 is 2.68 USD; for 3 months to 2025-09-30 was 2.86 USD. [1]
- Stockholders’ equity at 2026-09-30 is 16.55 billion; at 2026-06-30 it is 16.897 billion; at 2026-03-31 it is 16.476 billion. [1]
- Net income (year) for 12 months to 2025-12-31 is 3.552 billion; for 12 months to 2024-12-31 is 3.499 billion. [1]
- Net income (quarter) for 3 months to 2026-09-30 is 892 million; for 3 months to 2026-06-30 is 885 million; for 3 months to 2026-03-31 is 805 million. [1]
- Operating cash flow (year) for 12 months to 2025-12-31 is 9.851 billion; for 12 months to 2024-12-31 is 9.848 billion. [1]
- Operating cash flow (quarter) for 3 months to 2026-03-31 is 2.183 billion; for 2025-03-31 is 2.200 billion. [1]
- Shares outstanding at 2026-10-16 are 311,404,854; at 2026-07-17 are 325,370,840; at 2026-04-17 are 336,951,336; at 2026-01-30 are 347,596,279. [1]
- Total assets at 2026-09-30 are 122.469 billion; at 2026-06-30 are 121.93 billion; at 2026-03-31 are 121.501 billion. [1]
- Total liabilities at 2026-09-30 are 105.919 billion; at 2026-06-30 are 105.033 billion; at 2026-03-31 are 105.024 billion. [1]
- Latest 10-Q filed 2026-10-22; accession 0001601712-26-000043. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Net income (quarter) (3 months to 2026-09-30) | 892,000,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | 3,552,000,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-09-30) | 2.68 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | 9.28 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 2,183,000,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | 9,851,000,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-09-30) | 122,469,000,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-09-30) | 105,919,000,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-09-30) | 16,550,000,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-09-30) | 15,901,000,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-16) | 311,404,854 shares | sec-companyfacts | current |
Context
No reviewed context has been published for SYF. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add SYF to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: SYF.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.